NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has licensed a family of patents from Roche Molecular Systems covering uses of the 5' Nuclease process.
Novato, Calif.-based Biosearch plans to provide dual-labeled 5' Nuclease probes to Roche-licensed CLIA labs providing molecular diagnostic assay. The license provides Biosearch with freedom to operate, with respect to the Roche IP estate, for qPCR processes in the diagnostics research field, the firm said.
The firm will offer the licensed probes as custom analyte-specific reagents, and in vitro diagnostics and oligo components, Biosearch Director of Corporate Development Marc Beal said in a statement.
Financial terms of the agreement were not released.